Ocugen (OCGN) Cash & Equivalents Growth (1y) (2015 - 2025)
Ocugen (OCGN) Cash & Equivalents Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 15.53% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 90.42% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.50% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -4.13% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 43.32% |
| Jun 30, 2024 | -77.76% |
| Mar 31, 2024 | -61.36% |
| Dec 31, 2023 | -49.12% |
| Sep 30, 2023 | -47.37% |
| Jun 30, 2023 | -38.63% |
| Mar 31, 2023 | -47.40% |
| Dec 31, 2022 | -18.32% |
| Sep 30, 2022 | -5.35% |
| Jun 30, 2022 | -0.55% |
| Mar 31, 2022 | 189.72% |
| Dec 31, 2021 | 295.02% |
| Sep 30, 2021 | 461.86% |
| Jun 30, 2021 | 672.59% |
| Mar 31, 2021 | 1,302.82% |
| Dec 31, 2020 | 222.93% |
| Sep 30, 2020 | 24.87% |
| Jun 30, 2020 | 2,106.07% |
| Mar 31, 2020 | 934.28% |
| Dec 31, 2019 | 357.21% |